COMPANY

Trinity Biotech

Keywords: research tools

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Undisclosed round · $7M · announced Aug 14, 2026 Company release ↗
Source quote
- Aug 14, 2026 · Company release ↗
  “Trinity Biotech Secures Additional $7.0 Million Investment from Perceptive Advisors and Regains Compliance with Nasdaq Minimum Bid Price Requirement”

Raises announced in these releases: $7M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Aug 17, 2026 Partnership Partnership / licensing announced Aug 17, 2026. Source: SEC filing. source ↗
Aug 14, 2026 Raise Undisclosed round · $7M source ↗
Feb 25, 2026 Raise Private placement: $25M (total, as published), announced Feb 25, 2026. Source: SEC filing. source ↗
Nov 14, 2025 Partnership Partnership / licensing announced Nov 14, 2025. Source: SEC filing. source ↗
Dec 24, 2024 Debt Debt: $5M (not counted as a raise), announced Dec 24, 2024. Source: SEC filing. source ↗

Raised: $25.0M · Debt: $5.0M. Last 2 years.

Feb 25, 2026 Private placement: $25M (total, as published), announced Feb 25, 2026. Source: SEC filing. source ↗
Dec 24, 2024 Debt: $5M (not counted as a raise), announced Dec 24, 2024. Source: SEC filing. source ↗
Aug 17, 2026 Partnership / licensing announced Aug 17, 2026. Source: SEC filing. source ↗
Nov 14, 2025 Partnership / licensing announced Nov 14, 2025. Source: SEC filing. source ↗